These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 14744668)

  • 1. Neurocognitive sequelae of childhood cancers and their treatment.
    Mulhern RK; Butler RW
    Pediatr Rehabil; 2004; 7(1):1-14; discussion 15-6. PubMed ID: 14744668
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
    Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive effects of treatment for childhood cancer.
    Butler RW; Haser JK
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):184-91. PubMed ID: 17061287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late neurocognitive sequelae in survivors of brain tumours in childhood.
    Mulhern RK; Merchant TE; Gajjar A; Reddick WE; Kun LE
    Lancet Oncol; 2004 Jul; 5(7):399-408. PubMed ID: 15231246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
    Edelstein K; D'agostino N; Bernstein LJ; Nathan PC; Greenberg ML; Hodgson DC; Millar BA; Laperriere N; Spiegler BJ
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):450-8. PubMed ID: 21646917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychologic sequelae in the long-term survivors of childhood acute lymphoblastic leukemia.
    Cetingül N; Aydinok Y; Kantar M; Oniz H; Kavakli K; Yalman O; Erermiş S; Celebisoy N; Akyürekli O; Oztop S; Nişli G
    Pediatr Hematol Oncol; 1999; 16(3):213-20. PubMed ID: 10326219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of long-term neurocognitive outcomes in young children with acute lymphatic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Cohen IJ
    J Clin Oncol; 2007 Feb; 25(6):734-5; author reply 735. PubMed ID: 17308283
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
    Cole PD; Kamen BA
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):174-83. PubMed ID: 17061283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
    Mulhern RK; Khan RB; Kaplan S; Helton S; Christensen R; Bonner M; Brown R; Xiong X; Wu S; Gururangan S; Reddick WE
    J Clin Oncol; 2004 Dec; 22(23):4795-803. PubMed ID: 15570081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor analysis and validity of the Conners Parent and Teacher Rating Scales in childhood cancer survivors.
    Helton SC; Corwyn RF; Bonner MJ; Brown RT; Mulhern RK
    J Pediatr Psychol; 2006 Mar; 31(2):200-8. PubMed ID: 16467320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pediatric brain tumor late effects clinic.
    Dilley KJ; Lockart B
    Cancer Treat Res; 2009; 150():97-109. PubMed ID: 19834664
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuropsychological impact of treatment of brain tumors.
    De Luca CR; Conroy R; McCarthy MC; Anderson VA; Ashley DM
    Cancer Treat Res; 2009; 150():277-96. PubMed ID: 19834674
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropsychologic (cognitive) disabilities in long-term survivors of childhood cancer.
    Gamis AS; Nesbit ME
    Pediatrician; 1991; 18(1):11-9. PubMed ID: 1701051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cancer treatment on neural stem and progenitor cells.
    Dietrich J; Kesari S
    Cancer Treat Res; 2009; 150():81-95. PubMed ID: 19834663
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological complications in children.
    Partap S; Fisher PG
    Cancer Treat Res; 2009; 150():133-43. PubMed ID: 19834666
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychological and social impact of being a pediatric brain tumor survivor.
    Sands SA; Pasichow KP
    Cancer Treat Res; 2009; 150():297-307. PubMed ID: 19834675
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment.
    Janzen LA; Spiegler BJ
    Dev Disabil Res Rev; 2008; 14(3):185-95. PubMed ID: 18924154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMT for isolated central nervous system relapse in children with ALL.
    Hoogerbrugge PM; Vossen JM
    Bone Marrow Transplant; 1995 Dec; 16(6):859-60. PubMed ID: 8750287
    [No Abstract]   [Full Text] [Related]  

  • 20. Cranial radiation therapy and damage to hippocampal neurogenesis.
    Monje M
    Dev Disabil Res Rev; 2008; 14(3):238-42. PubMed ID: 18924155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.